Main Article Content
Abstract
Article Details
Authors who publish in the Jurnal Kedokteran dan Kesehatan Indonesia agree to the following terms:
- Authors retain copyright and grant Jurnal Kedokteran dan Kesehatan Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution Licence that allows others to adapt (remix, transform, and build) upon the work non-commercially with an acknowledgement of the work's authorship and initial publication in Jurnal Kedokteran dan Kesehatan Indonesia.
- Authors are permitted to share (copy and redistribute) the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Jurnal Kedokteran dan Kesehatan Indonesia.
References
- Batchelor P, Petersen K. Japanese encephalitis: A review of clinical guidelines and vaccine availability in Asia. Tropical Diseases, Travel Medicine and Vaccines. 2015;1(1):11.
- Kementerian Kesehatan Republik Indonesia. Kemenkes canangkan imunisasi cegah radang otak Japanese enchepalitis (JE). 2018.
- Barman B, Lynrah K, Pranjal Phukan. Japanese encephalitis. In 2015. Conference paper. Conference: APICON 2016, At Hyderabad, India.
- Basumatary LJ, Raja D, Bhuyan D, Das M, Goswami M, Kayal AK. Clinical and radiological spectrum of Japanese encephalitis. Journal of the Neurological Sciences. 2013;325(1–2):15–21.
- Robinson JS, Featherstone D, Vasanthapuram R, Biggerstaff BJ, Desai A, Ramamurty N, et al. Evaluation of three commercially available Japanese encephalitis virus IgM enzyme-linked immunosorbent assays. The American Journal of Tropical Medicine and Hygiene. 2010;83(5):1146–55.
- Swarup V, Ghosh J, Ghosh S, Saxena A, Basu A. Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis. Antimicrobial Agents and Chemotherapy.2007;51(9):3367–70.
- WHO. Weekly epidemiological record. Japanese encephalitis: Status of surveillance and immunization in asia and the Western Pacific, 2012. 2013.
References
Batchelor P, Petersen K. Japanese encephalitis: A review of clinical guidelines and vaccine availability in Asia. Tropical Diseases, Travel Medicine and Vaccines. 2015;1(1):11.
Kementerian Kesehatan Republik Indonesia. Kemenkes canangkan imunisasi cegah radang otak Japanese enchepalitis (JE). 2018.
Barman B, Lynrah K, Pranjal Phukan. Japanese encephalitis. In 2015. Conference paper. Conference: APICON 2016, At Hyderabad, India.
Basumatary LJ, Raja D, Bhuyan D, Das M, Goswami M, Kayal AK. Clinical and radiological spectrum of Japanese encephalitis. Journal of the Neurological Sciences. 2013;325(1–2):15–21.
Robinson JS, Featherstone D, Vasanthapuram R, Biggerstaff BJ, Desai A, Ramamurty N, et al. Evaluation of three commercially available Japanese encephalitis virus IgM enzyme-linked immunosorbent assays. The American Journal of Tropical Medicine and Hygiene. 2010;83(5):1146–55.
Swarup V, Ghosh J, Ghosh S, Saxena A, Basu A. Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis. Antimicrobial Agents and Chemotherapy.2007;51(9):3367–70.
WHO. Weekly epidemiological record. Japanese encephalitis: Status of surveillance and immunization in asia and the Western Pacific, 2012. 2013.